177 related articles for article (PubMed ID: 6237081)
1. A comparison of the ability of some radiosensitizers undergoing clinical trials to act as chemosensitizers.
Hinchliffe M; McNally NJ
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1635-40. PubMed ID: 6237081
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the effect of cytotoxic drugs by radiosensitizers.
Martin WM; McNally NJ; De Ronde J
Br J Cancer; 1981 Jun; 43(6):756-66. PubMed ID: 7248157
[TBL] [Abstract][Full Text] [Related]
3. The effect of timing on chemosensitization by clinical levels of SR-2508.
Hirst DG; Horsman MR; Brown JM; Hazlehurst JL
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1641-5. PubMed ID: 6237082
[TBL] [Abstract][Full Text] [Related]
4. Sensitization of normal and malignant tissue to cyclophosphamide by nitroimidazoles with different partition coefficients.
Hirst DG; Hazlehurst JL; Brown JM
Br J Cancer; 1984 Jan; 49(1):33-42. PubMed ID: 6229264
[TBL] [Abstract][Full Text] [Related]
5. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
Siemann DW
Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of cyclophosphamide cytotoxicity in vivo: a study with misonidazole and fifteen other 1-substituted 2-nitroimidazoles.
Chaplin DJ; Sheldon PW; Ahmed I; Adams GE
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1647-51. PubMed ID: 6480452
[TBL] [Abstract][Full Text] [Related]
7. Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
Brown JM; Hirst DG
Br J Cancer; 1982 May; 45(5):700-8. PubMed ID: 7082556
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
McNally NJ; Hinchliffe M; de Ronde J
Br J Cancer; 1983 Aug; 48(2):271-8. PubMed ID: 6882665
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
Siemann DW; Maddison K; Wolf K
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1657-60. PubMed ID: 6548212
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing the chemosensitization of melphalan by misonidazole.
Randhawa VS; Stewart FA; Denekamp J; Stratford MR
Br J Cancer; 1985 Feb; 51(2):219-28. PubMed ID: 3966979
[TBL] [Abstract][Full Text] [Related]
11. Hypoxic cell radiosensitizers: expectations and progress in drug development.
Coleman CN
Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):323-9. PubMed ID: 3156109
[TBL] [Abstract][Full Text] [Related]
12. Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508.
Yu NY; Brown JM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1265-9. PubMed ID: 6236185
[TBL] [Abstract][Full Text] [Related]
13. Modification of alkylating agent induced cell kill by 2-nitroimidazoles in unclamped and clamped SC 9L tumors.
Wallen CA; Moore SK; Wheeler KT
Int J Radiat Oncol Biol Phys; 1992; 22(4):727-30. PubMed ID: 1531976
[TBL] [Abstract][Full Text] [Related]
14. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
Law MP; Hirst DG; Brown JM
Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
[TBL] [Abstract][Full Text] [Related]
15. Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma.
Herman TS; Teicher BA; Holden SA; Pfeffer MR; Jones SM
Cancer Res; 1990 May; 50(9):2734-40. PubMed ID: 2139359
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
Horsman MR; Evans JW; Brown JM
Br J Cancer; 1984 Sep; 50(3):305-16. PubMed ID: 6466544
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic potential of misonidazole enhancement of alkylating agent cytotoxicity.
Hirst DG; Brown JM
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):639-42. PubMed ID: 7107389
[TBL] [Abstract][Full Text] [Related]
18. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
[TBL] [Abstract][Full Text] [Related]
19. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
[TBL] [Abstract][Full Text] [Related]
20. Enhanced tumor responses through therapies combining CCNU, MISO and radiation.
Siemann DW; Hill SA
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1623-6. PubMed ID: 6480451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]